The Manufacturers Life Insurance Company Has $344.07 Million Position in Nutrien Ltd. $NTR

The Manufacturers Life Insurance Company lowered its stake in shares of Nutrien Ltd. (NYSE:NTR) by 1.0% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,561,747 shares of the company’s stock after selling 45,860 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Nutrien were worth $344,067,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Guggenheim Capital LLC lifted its stake in shares of Nutrien by 2.2% in the fourth quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock worth $409,000 after buying an additional 145 shares during the last quarter. Minot DeBlois Advisors LLC boosted its holdings in shares of Nutrien by 1.8% during the 4th quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock worth $557,000 after buying an additional 164 shares during the period. Banque Cantonale Vaudoise grew its stake in Nutrien by 15.9% in the 1st quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock valued at $90,000 after buying an additional 164 shares during the last quarter. Gould Asset Management LLC CA grew its stake in Nutrien by 4.4% in the 1st quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock valued at $297,000 after buying an additional 165 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in Nutrien by 21.8% in the 4th quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock worth $61,000 after acquiring an additional 176 shares during the period. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Price Performance

NYSE:NTR opened at $67.46 on Tuesday. The stock has a market cap of $32.27 billion, a P/E ratio of 13.74, a PEG ratio of 0.67 and a beta of 0.62. Nutrien Ltd. has a one year low of $53.03 and a one year high of $85.36. The company has a fifty day moving average price of $66.44 and a 200 day moving average price of $70.14. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.24 and a quick ratio of 0.59.

Nutrien (NYSE:NTR) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.03. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.30 billion. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The business’s revenue was up 18.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.11 EPS. Analysts anticipate that Nutrien Ltd. will post 5.08 earnings per share for the current year.

Nutrien Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, July 17th. Investors of record on Tuesday, June 30th were paid a $0.55 dividend. This represents a $2.20 annualized dividend and a dividend yield of 3.3%. The ex-dividend date was Tuesday, June 30th. Nutrien’s dividend payout ratio (DPR) is presently 44.81%.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Oppenheimer cut their target price on shares of Nutrien from $82.00 to $80.00 and set an “outperform” rating for the company in a research report on Thursday, July 23rd. Royal Bank Of Canada raised their price target on Nutrien from $80.00 to $85.00 and gave the company an “outperform” rating in a research report on Tuesday, April 7th. Bank of America upgraded Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 price objective on the stock in a research note on Thursday, April 30th. UBS Group cut their price objective on Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a research report on Monday, May 11th. Finally, Scotiabank upgraded Nutrien from a “sector perform” rating to a “sector outperform” rating and set a $80.00 target price for the company in a research note on Tuesday, June 30th. Sixteen analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $81.94.

About Nutrien

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.